153 related articles for article (PubMed ID: 8958176)
1. Current perspectives on multidrug-resistant bacteria. Epidemiology and control.
Segal-Maurer S; Urban C; Rahal JJ
Infect Dis Clin North Am; 1996 Dec; 10(4):939-57. PubMed ID: 8958176
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Patel R; Rouse MS; Piper KE; Steckelberg JM
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):119-22. PubMed ID: 10354862
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in India and the United States.
Peter JB
Clin Infect Dis; 1996 Dec; 23(6):1315-6. PubMed ID: 8953081
[No Abstract] [Full Text] [Related]
4. Antibiotic resistance in bacteria. A current and future problem.
Liu HH
Adv Exp Med Biol; 1999; 455():387-96. PubMed ID: 10599374
[TBL] [Abstract][Full Text] [Related]
5. Resistance patterns among nosocomial pathogens: trends over the past few years.
Jones RN
Chest; 2001 Feb; 119(2 Suppl):397S-404S. PubMed ID: 11171776
[TBL] [Abstract][Full Text] [Related]
6. Current challenges in antibiotic resistance.
Hand WL
Adolesc Med; 2000 Jun; 11(2):427-38. PubMed ID: 10916132
[TBL] [Abstract][Full Text] [Related]
7. Infections due to drug-resistant pneumococci, enterococci, and Mycobacterium tuberculosis.
English BK; Chesney PJ
Pediatr Ann; 1996 Sep; 25(9):502-10. PubMed ID: 8880883
[No Abstract] [Full Text] [Related]
8. In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Patel R; Rouse MS; Piper KE; Steckelberg JM
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):177-9. PubMed ID: 11109018
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial-resistant pathogens in the 1990s.
Jacoby GA
Annu Rev Med; 1996; 47():169-79. PubMed ID: 8712771
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
Michel M; Gutmann L
Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771
[TBL] [Abstract][Full Text] [Related]
11. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
12. [Development of antibiotic resistance].
Bornkessel B
Med Monatsschr Pharm; 1997 Sep; 20(9):245-7. PubMed ID: 9379996
[No Abstract] [Full Text] [Related]
13. Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995.
Tokars JI; Paul SM; Crane GL; Cetron MS; Finelli L; Jarvis WR
Am J Infect Control; 1997 Oct; 25(5):395-400. PubMed ID: 9343623
[TBL] [Abstract][Full Text] [Related]
14. [Update on antibiotic resistance in Gram-positive bacteria].
Lozano C; Torres C
Enferm Infecc Microbiol Clin; 2017 Jan; 35 Suppl 1():2-8. PubMed ID: 28129816
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance patterns in long term geriatric care. Implications for drug therapy.
Mao CA; Siegler EL; Abrutyn E
Drugs Aging; 1996 Mar; 8(3):162-70. PubMed ID: 8720742
[TBL] [Abstract][Full Text] [Related]
16. Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.
Ho PL; Ng TK; Yung RW; Que TL; Yip EK; Tse CW; Yuen KY
J Antimicrob Chemother; 2001 Oct; 48(4):590-2. PubMed ID: 11581246
[No Abstract] [Full Text] [Related]
17. Antimicrobial activities of seven novel tetramethylpiperidine-substituted phenazines against multiple-drug-resistant Gram-positive bacteria.
Huygens F; O'Sullivan JF; van Rensburg CE
Chemotherapy; 2005 Aug; 51(5):263-7. PubMed ID: 16103666
[TBL] [Abstract][Full Text] [Related]
18. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management.
Fraimow HS; Abrutyn E
Infect Dis Clin North Am; 1995 Sep; 9(3):497-530. PubMed ID: 7490430
[TBL] [Abstract][Full Text] [Related]
19. Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children.
Fisher MC
Pediatr Infect Dis J; 1998 Sep; 17(9):825-6. PubMed ID: 9779772
[No Abstract] [Full Text] [Related]
20. Problems and dilemmas of antimicrobial resistance.
Murray BE
Pharmacotherapy; 1992; 12(6 Pt 2):86S-93S. PubMed ID: 1480504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
